Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment
- 29 May 1998
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 76 (5) , 729-737
- https://doi.org/10.1002/(sici)1097-0215(19980529)76:5<729::aid-ijc19>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effect of combination of suboptimal concentrations of P-glycoprotein blockers on the proliferation ofMDR1 gene expressing cellsInternational Journal of Cancer, 1996
- Decreased biotolerability for ivermectin and cyclosporin a in mice exposed to potent P‐glycoprotein inhibitorsInternational Journal of Cancer, 1995
- Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833Cancer Chemotherapy and Pharmacology, 1995
- Modulation of human P-glycoprotein epitope expression by temperature and/or resistance modulating agentsAnti-Cancer Drugs, 1994
- Extent and persistence of P-glycoprotein inhibition in multidrug-resistant P388 cells after exposure to resistance-modifying agentsAnti-Cancer Drugs, 1994
- Differential inhibition by cyclosporins of primary‐active ATP‐dependent transporters in the hepatocyte canalicular membraneFEBS Letters, 1993
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.Journal of Histochemistry & Cytochemistry, 1990
- The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues.Molecular and Cellular Biology, 1989
- Expression of a multidrug-resistance gene in human tumors and tissues.Proceedings of the National Academy of Sciences, 1987